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Abstract
Background: Although the red-tailed coral snake (Micrurus mipartitus) is widely distributed in Colombia and its
venom is highly neurotoxic and life threatening, envenomation by this species is rare. Therefore, this report may
shed some light on the clinical presentation of M. mipartitus bites.
Case presentations: Herein, we describe two cases of patients bitten by red-tailed coral snakes, illustrating the
clinical presentation of the victims, the outcomes and treatment provided.
Conclusion: Envenomation caused by M. mipartitus provokes predicable neurotoxicity, and its treatment should be
based on respiratory support and use of specific antivenom.
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Background
Envenomation caused by snake venoms remains a
neglected public health problem in most tropical coun-
tries. A better understanding of the venoms and clinical
aspects of snakebites facilitates the prevention and man-
agement of the victims [1, 2]. Colombia has a rich fauna
of reptiles, particularly venomous snakes. The red-tailed
coral snake Micrurus mipartitus is a member of the
Elapidae family that is found in Panamá, Colombia,
Ecuador and Venezuela. Despite its broad distribution in
Colombia, envenomation is rare. About 0.4% of reported
cases of envenomation by ophidians in the country are
due to coral snakes [3]. Possible causes for this include
low notification of cases, the evasive behavior of the
snake and the small size of its mouth (with little proter-
oglyphous fangs).
Accidents occur when the animal feels cornered or is
harassed without opportunity to escape. M. mipartitus is
common in agricultural areas of Colombia, especially
coffee and sugarcane crops. It has also been seen on the
Pacific Coast, the Western Oriental and Central Cordilleras,
as well as in the Sierra Nevada de Santa Marta. They can
be found in warm and cold climates, from 0 to 2,200 m
above sea level. They can reach up 122 cm in length and
have a cylindrical body, rounded small heads, very small
eyes and short thick tails. Typical specimens have bright
and smooth scales with 34–84 black body rings that are
separated by white or yellow rings, except for the second
head ring and three or four of the tail rings, which are
bright red, hence the popular names of cabeza de chocho
(referring to the red head of the seed of the legume
Erythrina rubrinervia), coral rabo de ají (in English: chili
pepper tail coral snake) or red-tailed coral snake [4] (Fig 1).
Timid, nocturnal and mostly subterranean, this M.
mipartitus tends to hide under weed, fallen leaves and
grasses. It is oviparous and its venom is neurotoxic, with
an estimated lethal dose 50% for mice (18–20 g body
weight) of 9 μg (450 μg/kg) [5]. This primarily neurotoxic
venom provokes progressive paralysis by neuromuscular
blockade and, if the inoculum is sufficient, death due to
respiratory arrest. The treatment is performed with
specific antivenom associated with respiratory support
including intensive care in special cases [6]. In this report,
we describe the clinical presentation and management of
two patients bitten by red-tailed coral snakes, treated at a
referral hospital in southwest Colombia.
Case presentations
Between 2005 and 2015, 97 patients were admitted at
Fundación Valle del Lili, a tertiary care university
hospital in Cali, Colombia, due to snake bites: 12 were
bitten by nonvenomous snakes (including non-venomous
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mimics), 79 by Bothrops and Bothriechis snakes and six
(7%) by red-tailed coral snakes (M. mipartitus). Snakes
were identified and classified by a biologist based on the
dead body that is usually brought by patients. M. miparti-
tus were classified according to phenotypic characteristics
[7]. Although in the geographical area of interest there are
other species of Micrurus, there are no records of patients
bitten by them during this period. False corals are present
in the area and their bites cause minor abrasions. Clinical
records of these six patients afflicted by red-tailed coral
snake bites were reviewed: three were asymptomatic (had
no neurological signs of envenomation, possibly due to
dry bites) and three suffered envenomation with neuro-
logical involvement. Herein, we describe the clinical
characteristics and treatment of the two representative
cases. The patients were bitten in the rural area of
Jamundí, a city located 24 km away from Cali, Colombia.
Case 1
A 46-year-old female was accidentally bitten on the
outer surface of her left foot by a M. mipartitus snake.
The length of the animal could not be measured because
its body was fragmented and some parts were lost. The
accident occurred in March 31, 2005 at 7:30 a.m. Thirty
minutes after the bite she complained of moderate pain
and progressive paresthesia in the foot and leg. After
that, she developed dysarthria, bilateral palpebral ptosis,
difficulty walking and decreased strength in the upper
limbs. Two hours after the bite, she was admitted to our
hospital.
On physical examination blood pressure was 100/
72 mmHg, pulse was 84 beats/min, temperature was
36.7 °C, O2SAT 82% and FiO2 21%. Neurological findings
were severe difficulty speaking, bilateral palpebral ptosis
(Fig. 2a), flaccid quadriparesis and quickly progressive
respiratory depression. There was diminished chest ex-
pansion. Her skin exhibited two small puncture wounds
on the outer edge of left foot, associated with mild edema,
with no signs of bleeding. Laboratory exams revealed that
blood count, erythrocyte sedimentation rate, C-reactive
protein, coagulation, renal and hepatic function were nor-
mal. Blood gases showed PO2 45 mmHg, PaCO2 48 mmHg
and pH 7.25. Endotracheal intubation and respiratory
support were required.
Eight vials of monovalent coral antivenom (each vial
containing 10 mL of equine lyophilized coral antivenom,
which neutralizes at least 1 μg of snake venom, manu-
factured by Laboratorios Probiol SA, Colombia) were
administered. No adverse reaction was observed. Six
hours after antivenom therapy, the blood gases (PO2
62 mmHg, PaCO2 40 mmHg and pH 7.41), respiratory
parameters and neurological examination were all
normal, and the patient was extubated (Fig. 2b). She
remained hospitalized for 24 additional hours for clinical
observation, after which she was discharged asymptom-
atic, with a normal physical examination.
Case 2
On October 8, 2010 at 8:30 a.m., a 22-year-old male
soldier was accidentally bitten by a red-tailed coral snake
of 72 cm in length at the first interdigital space of his
right hand. Thirty minutes after the bite he referred mild
pain and paresthesia on the right hand. Subsequently, he
developed dysarthria and bilateral palpebral ptosis.
Three hours after the bite he presented difficulty walking
and progressive respiratory distress. Military physicians
started bag-mask ventilation, and the patient was
transported by helicopter to our hospital. On physical
examination, blood pressure was 120/75 mmHg and
pulse was 94 beats/min. Neurologic examination demon-
strated bilateral palpebral ptosis and flaccid quadripar-
esis. Cardiopulmonary examination revealed diminished
chest expansion. A puncture wound on the first
interdigital area of right hand was present, with no
edema or signs of bleeding. Full blood count, erythrocyte
sedimentation rate, C-reactive protein, coagulation, renal
and hepatic function tests were normal. Blood gases
showed hypoxemia and moderate hypercapnia (PO2
40 mmHg, PaCO2 50 mmHg).
The patient was then intubated and respiratory support
was administered. Six vials of monovalent antivenom
(each vial containing 10 mL of equine lyophilized
coral antivenom, which neutralizes at least 1 μg of
snake venom, manufactured by Laboratorios Probiol
SA, Colombia) were applied. The patient had progressive
improvement of respiratory parameters, neurological
examination and blood gases; therefore extubation was
decided 20 h after the admission. He was discharged from
hospital 24 h later.
Fig. 1 Micrurus mipartitus (red-tailed coral snake). Typical specimen
with black body rings separated by white ones, except for the
second head ring (red) and three or four of the tail rings
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Discussion
Envenomation by M. mipartitus provokes paralysis due
to the neuromuscular blockage of nicotinic acetylcholine
receptors elicited by an α-neurotoxin member of the
three-finger toxin superfamily [8]. A component of this
venom is called mipartoxin-I, which presents the charac-
teristic cysteine signature and amino acid sequence
length of the short-chain type-I α-neurotoxins [8, 9].
Mipartoxin-I has shown a potent lethal effect on mice
(intraperitoneal median lethal dose: 0.06 μg/g body
weight), and causes a strong neuromuscular blockade on
both avian and mouse nerve-muscle preparations, pre-
senting a post-synaptic action through the cholinergic
nicotinic receptor. M. mipartitus venom provokes a
concentration dependent inhibition (3–10 μg/mL) of
nerve-mediated twitches and significantly inhibits con-
tractile responses to exogenous ACh (1 mM), but not to
KCl (40 mM), which indicates a postsynaptic mechanism
of action [9].
Since mipartoxin-I is the most abundant (28%) protein
in M. mipartitus venom, it has been postulated that it
should play a major role in its toxicity [10]. Anticholin-
esterase agents such as neostigmine have proven to re-
verse the effects of M. frontalis venom on animal model
and may be useful in the treatment of some patients
[11]. These agents were not employed in the treatment
of M. mipartitus envenomation of the present report.
The patients of this report exhibited a predictable
clinical pattern. Typically, bites affected hands or feet,
places reachable by these species. Bite sites presented
small skin disruptions, and mild to moderate pain and
mild edema. In a first phase of the envenomation,
minutes after bites, patients complain of local pain and
paresthesia. Next, depending on the inoculum, systemic
neurological envenomation appears. In severe cases,
neurological manifestations are present within 30 min
after the bite. In the second neurological phase, symptoms
may delay one or two hours. Patients usually present
Fig. 2 a Case 1, woman bitten by M. mipartitus with characteristic palpebral ptosis. b Total neurological recovery after treatment
Table 1 Clinical manifestations of envenoming by M. mipartitus in two patients
Gender, age,
bite site
Phase 1 – Initial
manifestations
Phase 2 – Neurological symptoms and
signs before respiratory arrest – Treatment
Phase 3 – Neurological symptoms and signs
after respiratory arrest with patient with
respiratory assistance
Case 1, female,
46 y.o., left foot
Onset: 30 min. after the
bite, moderate local pain
and paresthesia
Onset: One hour after the bite, she shows
dysarthria and bilateral palpebral ptosis
Two hours after the bite: difficulty walking
and decreased strength in the upper limbs
Three hours after the bite: severe difficulty
speaking and progressive respiratory
depression – respiratory support and antivenom
Progressive recovery. Extubation: six hours
after the antivenom application
Case 2 male,
22 y.o., right hand
Onset: 30 min. after the
bite, local pain and
paresthesia
Onset: Two hours after the bite, he developed
dysarthria and bilateral palpebral ptosis
Three hours after the bite: he presented difficulty
walking and progressive respiratory distress –
respiratory support and antivenom
Progressive recovery. Extubation: 20 h after
the antivenom application
y.o. years old; min. minutes
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progressive bilateral ptosis and difficulty speaking and
later progressive loss of muscle strength in extremities
and difficulty walking. They may develop other manifesta-
tions including salivation and drowsiness. Afterwards,
there is respiratory paralysis. Neurointoxication, then, first
affects cranial nerves synapses, and only later nerves con-
trolling respiratory muscles. Flaccid quadriparesis usually
occur. A third phase (severe flaccid quadriplegia) comes
when the patient has been kept alive by assisted ventila-
tion. Without treatment, M. mipartitus envenomation can
be lethal. Fortunately, specific antivenom reverses the
effects of envenomation. If the patient receives only mech-
anic ventilation, reversion of paralysis may take several
weeks [12]. Table 1 shows symptoms and signs of our two
patients in relation to time after bites.
Cases of envenomation by M. mipartitus from
Colombia had been previously reported. In 1987, Angel-
Mejia R. [13] described three cases from the northeastern
region of the country. The first victim was a 5-year-old girl
with mild envenomation that recovered without respira-
tory support. The second was a woman of 27 years old
who had a severe envenomation and was admitted to the
hospital 15 h after the bite with severe respiratory distress.
She was treated with mechanical ventilation and nine vials
of Costa Rica antivenom, and presented progressive recov-
ery. The third victim was 50-year-old man treated with
mechanical ventilation who did not receive antivenom
and recovered after 14 days. An extension of the latter
historic case occurred in the city of Manizales in 1968 and
was recently reported [13]. Otero-Patiño et al. [14] and
Badillo et al. [15] reported two additional cases from
northwestern and northeastern Colombia, respectively.
Herein, we described two new cases of envenomed pa-
tients by red-tailed coral snake, illustrating its clinical
presentation and outcome with antivenom treatment.
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